activins and Muscular Atrophy

activins has been researched along with Muscular Atrophy in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (5.26)	29.6817
2010's	12 (63.16)	24.3611
2020's	6 (31.58)	2.80

Authors

Authors	Studies
Ikizler, TA; Terker, AS	1
Koniaris, LG; Liu, S; Liu, Y; Narasimhan, A; Shahda, S; Silverman, LM; Wan, J; Young, AR; Zhong, X; Zimmers, TA	1
Ballarò, R; Baumann, M; Euro, L; Hentilä, J; Hulmi, JJ; Lalowski, M; Lautaoja, JH; Nissinen, TA; Penna, F; Pirinen, E; Pöllänen, N; Ritvos, O; Soliymani, R	1
Cao, Z; Glab, J; Hoogenraad, NJ; Jose, I; Osellame, LD; Puthalakath, H	1
Chandok, H; George, J; Germain-Lee, EL; Gogain, J; Koch, C; Lee, SJ; Lehar, A; Liu, Y; Meir, JU; Michaud, M; Morgan, A; Rydzik, R; Stoklasek, TA; Warren, LE; Youngstrom, DW	1
Boor, P; Cohen, CD; Eichinger, F; Hoxha, E; Huber, TB; Kilic, T; Klinkhammer, BM; Kretz, O; Kretzler, M; Kylies, D; Lindenmeyer, MT; Liu, S; Lu, S; Martin, IV; Matsakas, A; Menon, R; Meyer, C; Mitchell, R; Nair, V; Omairi, S; Ostendorf, T; Paolini, A; Pasternack, A; Patel, K; Puelles, VG; Ritvos, O; Sandri, M; Solagna, F; Tezze, C; Tharaux, PL; Turner, JE; Wanner, N; Wiesch, JSZ; Wu, G; Zhao, Y	1
Bao, R; Gupta, MP; Kanwal, A; Pillai, VB; Samant, SA	1
Marchetti, N	1
Chen, R; Ding, H; Fu, X; Gui, X; Ji, X; Zhou, G	1
Ceppa, EP; Couch, ME; House, MG; Jiang, G; Jiang, Y; Koniaris, LG; Liu, J; Liu, Y; Nakeeb, A; Poirier, C; Pons, M; Sandusky, GE; Schmidt, CM; Shahda, S; Zhong, X; Zimmers, TA; Zyromski, NJ	1
Chen, JL; Gregorevic, P; Harrison, CA; Lynch, GS; Makanji, Y; Murphy, KT; Qian, H; Thomson, RE; Walton, KL; Winbanks, CE	1
Gregorevic, P; Sandri, M; Sartori, R	1
Bachl, N; Franzke, B; Halper, B; Hofmann, M; Oesen, S; Ploder, M; Quittan, M; Strasser, EM; Stuparits, P; Tschan, H; Wagner, KH; Wessner, B	1
Adachi, S; Handa, O; Ishikawa, T; Itoh, Y; Kamada, K; Katada, K; Kimura, R; Kokura, S; Matsuyama, T; Mizushima, K; Naito, Y; Oka, K; Okajima, M; Okayama, T; Sakai, H; Sakamoto, N; Takagi, T; Uchiyama, K	1
Fujino, M; Fukai, Y; Hagiwara, H; Hayashi, Y; Itoh, F; Murakami, T; Nishimatsu, S; Ohsawa, Y; Okada, T; Sunada, Y; Takayama, K; Tsuchida, K	1
Bertona, M; Emanuele, E; Fiuza-Luces, C; Lucia, A; Morales, JS; Pareja-Galeano, H; Sanchis-Gomar, F	1
Gilson, H; Kalista, S; Lause, P; Schakman, O; Thissen, JP; Tsuchida, K	1
Boone, T; Chen, Q; Goldberg, AL; Han, HQ; Jiao, Q; Kwak, KS; Lacey, DL; Lu, J; Rosenfeld, R; Simonet, WS; Song, Y; Wang, JL; Zhou, X	1
Fearon, KC; Glass, DJ; Guttridge, DC	1

Reviews

2 review(s) available for activins and Muscular Atrophy

Article	Year
TGFβ and BMP signaling in skeletal muscle: potential significance for muscle-related disease. Trends in endocrinology and metabolism: TEM, 2014, Volume: 25, Issue:9 Topics: Activin Receptors; Activins; Animals; Autophagy; Bone Morphogenetic Protein Receptors; Bone Morphogenetic Proteins; Humans; Hypertrophy; Mice, Knockout; Mice, Transgenic; Models, Biological; Muscle, Skeletal; Muscular Atrophy; Muscular Diseases; Protein Isoforms; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta	2014
Cancer cachexia: mediators, signaling, and metabolic pathways. Cell metabolism, 2012, Aug-08, Volume: 16, Issue:2 Topics: Activins; Cachexia; Humans; Interleukin-6; Lipolysis; Metabolic Networks and Pathways; Models, Biological; Muscular Atrophy; Myostatin; Neoplasms; Signal Transduction; Tumor Necrosis Factor-alpha	2012

Article

Year

TGFβ and BMP signaling in skeletal muscle: potential significance for muscle-related disease.

Trends in endocrinology and metabolism: TEM, 2014, Volume: 25, Issue:9

Topics: Activin Receptors; Activins; Animals; Autophagy; Bone Morphogenetic Protein Receptors; Bone Morphogenetic Proteins; Humans; Hypertrophy; Mice, Knockout; Mice, Transgenic; Models, Biological; Muscle, Skeletal; Muscular Atrophy; Muscular Diseases; Protein Isoforms; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta

2014

Cancer cachexia: mediators, signaling, and metabolic pathways.

Cell metabolism, 2012, Aug-08, Volume: 16, Issue:2

Topics: Activins; Cachexia; Humans; Interleukin-6; Lipolysis; Metabolic Networks and Pathways; Models, Biological; Muscular Atrophy; Myostatin; Neoplasms; Signal Transduction; Tumor Necrosis Factor-alpha

2012

Other Studies

17 other study(ies) available for activins and Muscular Atrophy

Article	Year
Untangling the fibers of sarcopenia: activin A in chronic kidney disease-associated muscle wasting. Kidney international, 2022, Volume: 101, Issue:2 Topics: Activins; Humans; Muscles; Muscular Atrophy; Renal Insufficiency, Chronic; Sarcopenia	2022
Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin. Journal of cachexia, sarcopenia and muscle, 2022, Volume: 13, Issue:4 Topics: Activins; Adenocarcinoma; Animals; Cachexia; Carcinoma, Pancreatic Ductal; Estradiol; Female; Follistatin-Related Proteins; Humans; Male; Mice; Muscle, Skeletal; Muscular Atrophy; Pancreatic Neoplasms; Phenotype; Sex Factors	2022
Muscle NAD Molecular metabolism, 2020, Volume: 41 Topics: Activin Receptors; Activins; Acute-Phase Proteins; Animals; Cachexia; Cell Line, Tumor; Disease Models, Animal; Male; Mice; Mitochondria; Muscle, Skeletal; Muscular Atrophy; Myostatin; NAD; Oxidative Phosphorylation; Serpins	2020
Generation of reporter cell lines for factors inducing muscle wasting in cancer cachexia. Analytical biochemistry, 2020, 10-01, Volume: 606 Topics: Activins; Animals; Cachexia; Cell Line, Transformed; Genes, Reporter; Green Fluorescent Proteins; Humans; Mice; Mice, Inbred C57BL; Muscular Atrophy; Myoblasts; Myostatin; Neoplasms; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases	2020
Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight. Proceedings of the National Academy of Sciences of the United States of America, 2020, 09-22, Volume: 117, Issue:38 Topics: Activin Receptors, Type II; Activins; Animals; Bone Resorption; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy; Myostatin; Signal Transduction; Space Flight	2020
Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs. The Journal of clinical investigation, 2021, 06-01, Volume: 131, Issue:11 Topics: Activin Receptors, Type II; Activins; Animals; Cachexia; Disease Models, Animal; HEK293 Cells; Humans; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy; Renal Insufficiency, Chronic; Wasting Syndrome	2021
The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy. Scientific reports, 2017, 09-19, Volume: 7, Issue:1 Topics: Activin Receptors, Type II; Activins; Angiotensin II; Animals; Humans; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy; Myocardium; Myostatin; NF-kappa B; Rats; Response Elements; Sirtuins; Up-Regulation	2017
Anabolic Medications for Muscle Wasting in Chronic Obstructive Pulmonary Disease. Is the Evidence Getting Stronger? American journal of respiratory and critical care medicine, 2019, 02-01, Volume: 199, Issue:3 Topics: Activin Receptors; Activins; Humans; Muscular Atrophy; Pulmonary Disease, Chronic Obstructive	2019
Elevated serum Activin A in chronic obstructive pulmonary disease with skeletal muscle wasting. Clinics (Sao Paulo, Brazil), 2019, Volume: 74 Topics: Activins; Adult; Aged; Body Mass Index; Cachexia; Case-Control Studies; Female; Humans; Inhibin-beta Subunits; Male; Middle Aged; Muscle, Skeletal; Muscular Atrophy; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha	2019
The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy. Journal of cachexia, sarcopenia and muscle, 2019, Volume: 10, Issue:5 Topics: Activin Receptors, Type II; Activins; Animals; Biomarkers; Body Weights and Measures; Cachexia; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Disease Management; Disease Models, Animal; Gene Expression; Humans; Immunohistochemistry; Mice; Muscle Fibers, Skeletal; Muscular Atrophy; Pancreatic Neoplasms; Prognosis; Proportional Hazards Models	2019
Elevated expression of activins promotes muscle wasting and cachexia. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014, Volume: 28, Issue:4 Topics: Activin Receptors, Type II; Activins; Animals; Blotting, Western; Cachexia; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dependovirus; Gene Expression; Genetic Vectors; Humans; MCF-7 Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myostatin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; SKP Cullin F-Box Protein Ligases	2014
Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women. Experimental gerontology, 2015, Volume: 64 Topics: Activins; Adult; Age Factors; Aged; Aged, 80 and over; Austria; Biomarkers; Body Composition; Comorbidity; Female; Follistatin; Growth Differentiation Factor 15; Humans; Insulin-Like Growth Factor I; Muscular Atrophy; Myostatin; Physical Examination; Regression Analysis; Sarcopenia; TGF-beta Superfamily Proteins; Young Adult	2015
Tumor inoculation site affects the development of cancer cachexia and muscle wasting. International journal of cancer, 2015, Dec-01, Volume: 137, Issue:11 Topics: Activins; Animals; Cachexia; Cell Line, Tumor; Disease Models, Animal; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myocardium; RNA, Messenger; SKP Cullin F-Box Protein Ligases; Transforming Growth Factor beta; Tripartite Motif Proteins; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases	2015
The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy. PloS one, 2015, Volume: 10, Issue:7 Topics: Activins; Animals; Caveolin 3; Cell Differentiation; Cell Line; Cell Membrane Structures; Chlorocebus aethiops; COS Cells; Growth Differentiation Factors; HEK293 Cells; Humans; Ligands; Male; Mice; Muscle, Skeletal; Muscular Atrophy; Muscular Dystrophies, Limb-Girdle; Myoblasts; Myostatin; Protein Structure, Tertiary; Receptors, Cell Surface; Transforming Growth Factor beta1	2015
Baicalin supplementation reduces serum biomarkers of skeletal muscle wasting and may protect against lean body mass reduction in cancer patients: Results from a pilot open-label study. Neuro endocrinology letters, 2016, Volume: 37, Issue:3 Topics: Absorptiometry, Photon; Activins; Aged; Biomarkers; Body Weight; Cachexia; Endpoint Determination; Female; Flavonoids; Humans; Male; Middle Aged; Muscle, Skeletal; Muscular Atrophy; Neoplasms; NF-kappa B; Pilot Projects; Wasting Syndrome; Weight Loss	2016
Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. American journal of physiology. Endocrinology and metabolism, 2009, Volume: 297, Issue:1 Topics: Activins; Animals; Cell Proliferation; Follistatin; Hypertrophy; Male; Mice; Mice, Knockout; Muscular Atrophy; Myostatin; Rats; Rats, Transgenic; Rats, Wistar; Satellite Cells, Skeletal Muscle; Up-Regulation	2009
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell, 2010, Aug-20, Volume: 142, Issue:4 Topics: Activin Receptors, Type II; Activins; Animals; Anorexia; Atrophy; Cachexia; Female; Humans; Inhibins; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myoblasts; Myocardium; Neoplasm Transplantation; Neoplasms; Signal Transduction; Transplantation, Heterologous; Tumor Necrosis Factor-alpha	2010